Contraline has a total of 31 patents globally, out of which 5 have been granted. Of these 31 patents, more than 74% patents are active. The United States of America is where Contraline has filed the maximum number of patents, followed by Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Contraline.
Contraline was founded in 2015. Contraline is a biotechnology company. The company creates an exclusive injectable hydrogel platform for use in applications related to contraception and reproduction.
Do read about some of the most popular patents of Contraline which have been covered by us in this article and also you can find Contraline patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Contraline patent portfolio.
How many patents does Contraline have?
Contraline has a total of 31 patents globally. These patents belong to 6 unique patent families. Out of 31 patents, 23 patents are active.
How Many Patents did Contraline File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Contraline Applications Filed | Contraline Patents Granted |
| 2023 | – | 1 |
| 2022 | 4 | 3 |
| 2021 | 6 | – |
| 2020 | 2 | 1 |
| 2019 | 7 | – |
| 2018 | 10 | – |
| 2017 | 2 | – |
How many Contraline patents are Alive/Dead?
Worldwide Patents
How Many Patents did Contraline File in Different Countries?
Countries in which Contraline Filed Patents
| Country | Patent |
| United States Of America | 14 |
| Canada | 4 |
| Australia | 3 |
| Europe | 3 |
| Japan | 1 |
Where are Research Centers of Contraline Patents Located?
The Research Centers of Contraline Patents is the United States of America.
10 Best Contraline Patents
US20190053790A1 is the most popular patent in the Contraline portfolio. It has received 19 citations so far from companies like Maxwell Biosciences, The Ncs Testing Technology, Hebei Aineng Biotechnology.
Below is the list of 10 most cited patents of Contraline:
| Publication Number | Citation Count |
| US20190053790A1 | 19 |
| US20180028715A1 | 11 |
| EP3275469A1 | 10 |
| US20190038454A1 | 9 |
| WO2021035217A1 | 9 |
| US20200237388A1 | 8 |
| WO2019070632A1 | 5 |
| WO2020102234A1 | 4 |
| WO2018129369A1 | 4 |
| US10751124B2 | 3 |
What Percentage of Contraline US Patent Applications Were Granted?
Contraline (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 80%.
Below are the key stats of Contraline patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Contraline?
| Law Firm | Total Applications | Success Rate |
| Ambrose Mills & Lazarow Pllc | 4 | 100% |
| New River Valley IP | 3 | 0% |
| Contraline Inc | 1 | 100% |
List of Contraline patents
| Contraline Patents | Title |
| US11510807B2 | Systems And Methods For Delivering Biomaterials |
| US11318040B2 | Systems And Methods For Delivering Biomaterials |
| US11253391B2 | Systems And Methods For Delivering Biomaterials |
| US10751124B2 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
| US20230190515A1 | Biomaterial Compositions And Methods Of Delivery |
| US20230116862A1 | Systems And Methods For Delivering Biomaterials |
| US20220313475A1 | Systems And Methods For Delivering Biomaterials |
| US20220175672A1 | Compositions And Methods For Sustained Drug Release From An Injectable Hydrogel |
| US20220015742A1 | Systems And Methods For Automated Image Recognition Of Implants And Compositions With Long-Lasting Echogenicity |
| US20200352649A1 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
| US20190038454A1 | Long-Lasting And Degradable Implant Compositions |
| US20180028715A1 | Carbon-Based Compositions Useful For Occlusive Medical Devices And Methods Of Making And Using Them |
| EP3880273A4 | Systems And Methods For Delivering Biomaterials |
| EP3565484A4 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
| EP3275469A1 | Carbon-Based Compositions Useful For Occlusive Medical Devices And Methods Of Making And Using Them |
| AU2018205258B2 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
| AU2021273196A1 | Biomaterial Compositions And Methods Of Delivery |
| AU2019380413A1 | Systems And Methods For Delivering Biomaterials |
| JP2022506078A5 | Systems And Methods For Delivering Biomaterials |
| CA3183275A1 | Biomaterial Compositions And Methods Of Delivery |
| CA3117577A1 | Systems And Methods For Delivering Biomaterials |
| CA3078365A1 | Methods And Apparatus For Delivering A Stimulus To An Occlusive Implant |
| CA3053451A1 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
| US20200237388A1 | Methods And Apparatus For Delivering A Stimulus To An Occlusive Implant |
| US20190053790A1 | Systems And Methods For Automated Image Recognition Of Implants And Compositions With Long-Lasting Echogenicity |
| WO2021243046A1 | Systems And Methods For Removing Biomaterial Implants |
| WO2021231717A1 | Biomaterial Compositions And Methods Of Delivery |
| WO2021035217A1 | Compositions And Methods For Sustained Drug Release From An Injectable Hydrogel |
| WO2020102234A1 | Systems And Methods For Delivering Biomaterials |
| WO2019070632A1 | Methods And Apparatus For Delivering A Stimulus To An Occlusive Implant |
| WO2018129369A1 | Methods For Implanting And Reversing Stimuli-Responsive Implants |
What are Contraline key innovation segments?
What Technologies are Covered by Contraline?
The chart below distributes patents filed by Contraline